DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates

Mostrar otras versiones (1)

Anxiety disorders are among the most prevalent psychiatric disorders, with symptoms often beginning early in life. To model the pathophysiology of human pathological anxiety, we utilized Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) in a nonhuman primate model of anxious tempe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Sascha A.L., Oler, Jonathan A., Roseboom, Patrick H., Aggarwal, Nakul, Kenwood, Margaux M., Riedel, Marissa K., Elam, Victoria R., Olsen, Miles E., DiFilippo, Alexandra H., Christian, Bradley T., Hu, Xing, Galvan, Adriana, Boehm, Matthew A., Michaelides, Michael, Kalin, Ned H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663133/
https://www.ncbi.nlm.nih.gov/pubmed/38020807
http://dx.doi.org/10.1016/j.crneur.2023.100111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663133/
https://www.ncbi.nlm.nih.gov/pubmed/38020807
http://dx.doi.org/10.1016/j.crneur.2023.100111

Ejemplares similares